You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Clinical Trials Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009.32.
[Abstract][Full text][]
Clinical Implications of Basic Neuroscience Research Implications of Amylin Receptor Agonism: Integrated Neurohormonal Mechanisms and Therapeutic Applications
Jonathan D. Roth; Holly Maier; Steve Chen; Barbara L. Roland
Arch Neurol 2009; 66: 306-310.
[Extract][Full text][PDF]
Correspondence Medications Impair Kidney Function in Stroke Population—Reply
Observations Long-term B-Lymphocyte Depletion With Rituximab in Patients With Relapsing-Remitting Multiple Sclerosis
Olaf Stüve; Verena I. Leussink; Ruth Fröhlich; Bernhard Hemmer; Hans-Peter Hartung; Til Menge; Bernd C. Kieseier
Arch Neurol 2009; 66: 259-261.
[Abstract][Full text][PDF]
Editorials Defining Multiple Sclerosis Treatment Response With Magnetic Resonance Imaging: How Much Activity Is Too Much?
Paul S. Giacomini; Douglas L. Arnold; Amit Bar-Or; Jack P. Antel
Arch Neurol 2009; 66: 19-20.
[Extract][Full text][PDF]
Neurological Reviews A Renaissance for Antisense Oligonucleotide Drugs in Neurology: Exon Skipping Breaks New Ground
Toshifumi Yokota; Shinichi Takeda; Qi-Long Lu; Terence A. Partridge; Akinori Nakamura; Eric P. Hoffman
Arch Neurol 2009; 66: 32-38.
[Abstract][Full text][PDF]
Original Contributions Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis: A 3-Year Monthly Imaging Study
Annie W. Chiu; Nancy Richert; Mary Ehrmantraut; Joan Ohayon; Shiva Gupta; Giuseppe Bomboi; Deeya Gaindh; Fredric K. Cantor; Joseph A. Frank; Henry F. McFarland; Francesca Bagnato
Arch Neurol 2009; 66: 39-43.
[Abstract][Full text][PDF]